For these two neurotransmitter (Melatonin & Norepinephrine), please discuss the following: pharmacologic action, the drug class it is most closely linked to, expected outcomes, and potential side effects. Based on this information, which condition would these neurotransmitters be considered for the treatment plan?
The post Neurotransmitter (Melatonin & Norepinephrine) first appeared on COMPLIANT PAPERS.
